Anti-tumor gene therapy

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 217-223

  Cirielli, C ^a   Capogrossi, M C ^b   Passaniti, A ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Adenovirus; Gene therapy; Liposome; Retrovirus

Indexed keywords

CYTOKINE; LIPOSOME; PROTEIN P53; THYMIDINE KINASE;

ADENOVIRUS; BRAIN TUMOR; CANCER INHIBITION; CANCER THERAPY; CYTOTOXICITY; EXPRESSION VECTOR; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; HEALTH STATUS; HUMAN; IMMUNOREACTIVITY; MELANOMA; NEUROENDOCRINE TUMOR; NONHUMAN; ONCOGENE; ONCOGENE RAS; RETROVIRUS; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031058429     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005791012205     Document Type: Review

References (67)

1. Fujiwara T, Grimm EA, Roth JA: Gene therapeutics and gene therapy for cancer. Curr Opin Oncol 6: 96-105, 1994
2. Nabel EG, Plautz G, Nabel GJ: Gene transfer into vascular cells. J Am Coll Cardiol 17: 189B-194B, 1991
3. Kimura O, Yamaguchi Y, Gunning KB, Teeter LD, Husain F, Kuo MT: Retroviral delivery of DNA into the livers of transgenic mice bearing pemalignant and malignant hepatocellular carcinomas. Hum Gen Ther 5: 845-52, 1994
4. Zhang WW, Roth JA: Anti-oncogene and tumor suppressor gene therapy: examples from a lung cancer animal model. In Vivo 8: 755-69, 1994
5. Zatloukal K, Schmidt W, Cotten M, Wagner E, Stingl G, Birnstiel ML: Somatic gene therapy for cancer: the utility of transferrinfection in generating 'tumor vaccines'. Gene 135: 199-207, 1993
6. Brody SL, Crystal RG: Adenovirus-mediated in vivo gene transfer. Ann NY Ac Sci 716: 90-101, 1994
7. Miller N, Vile R: Targeted vectors for gene therapy. FASEB J 9: 190-199, 1995
8. Mizuno M, Yoshida J, Oyama H, Sugita K: Growth inhibition of glioma cells by liposome-mediated cell transfection with tumor necrosis factor-alpha gene: its enhancement by prior gamma-interferon treatment. Neur Med-Chir 32: 873-6, 1992
9. Isobe K, Fan ZH, Emi N, Nakashima I: Gene transfer of TNF receptor for treatment of cancer by TNF. Bioch Biophys Res Commun 202: 1538-42, 1994
10. Nabel EG, Yang Z, Muller D, Chang AE, Gao X, Huang L, Cho KJ, Nabel GJ: Safety and toxicity of catheter gene delivery to pulmonary vasculature in a patient with metastatic melanoma. Hum Gen Ther 5: 1089-94, 1994
11. Nabel EG et al.: Human gene markers/therapy: Clinical Protocols. Hum Gen Ther 4: 547-554, 1993
12. Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowall NW, Hochberg FH, Waxman DJ, Breakefield, Chiocca EA: Experimental tumor therapy in mice using the cyclophosphamide-activating cytocrome P450 2B1 gene. Hum Gen Ther 5: 969-78, 1994
13. Zatloukal K, Schneeberg A, Berger M, Koszik F, Schmidt W, Wagner E, Cotten M, Buschle M, Maass G, Stingl G: Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancer. Verhandlungen der deutschen Gesellschaft für Pathologie 78: 171-6, 1994
14. Cordier L, Duffour MT, Sabourin JC, Lee MG, Cabannes J, Ragot T, Perricaudet M, Haddada H: Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther 1: 16-21, 1995
15. Zitvogel L,Tahara H. Cai Q. Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT: Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gen Ther 5: 1493-1506, 1994
16. Hasegawa Y, Emi N, Shimokata K, Hasegawa T, Kirioka T, Saito H: Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell line using retroviral vectors. Am J Resp Cell Mol Biol 8: 655-61, 1993
17. Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM: Use of recombinant adenovirus to transfer the herpes simplex virus thimidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54: 2055-9, 1994
18. Smythe WR, Hwang HC, Elshami AA, Amin KM, Albelda SM, Kaiser LR: Differential sensitivity of thoracic tumors to adenovirus-mediated drug sensitization gene therapy. J Thor Cardiovasc Surg 109: 626-30, 1995
19. Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO, Martuza RL: Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thimidine kinase gene and wild type retrovirus kills tumor cells. J Neurosc Res 33: 493-503, 1992
20. Bi WL, Parysek LM, Warnick R, Stambrook PJ: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gen Ther 4: 725-31, 1993
21. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gen Ther 4: 39-69, 1993
22. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta T, Breakefield XO, Martuza RL: An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurgery 79: 104-10, 1993
23. Ram Z, Walbridge S, Oshiro EM, Viola JJ, Chiang Y, Mueller SN, Blaese RM, Oldfield EH: Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 54: 2141-5, 1994
24. Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M, Spence AM: Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 91: 8185-9, 1994
25. Wu JK, Cano WG, Meylaerts SA, Qi P, Vrionis F, Cherington V: Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35: 1094-102, 1994
26. Izquierdo M, Cortes M, de Felipe P, Martin V, Diez-Guerra J, Talavera A, Perez-Higueras A: Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther 2: 66-9, 1995
27. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD: Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 39: 506-11, 1994
28. Smythe WR, Hwang HC, Elshami AA, Amin KM, Albelda SM, Kaiser LR: Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy. J Thor Cardiovasc Surg 109: 626-30, 1995
29. Bonnekoh B, Greenhalgh DA, Bundman DS, Eckhardt JN, Longley MA, Chen SH, Woo SL, Roop DR: Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J Invest Dermatol 104: 313-7, 1995
30. O'Malley BW Jr, Chen SH, Schwartz MR, Woo SL: Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080-5, 1995
31. Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT: Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of anti-ras ribozyme. Cancer Res 55: 2024-8, 1995
32. Lesoon-Wood LA, Kim WH, Kleinman HK, Weintraub BD, Mixson AJ: Systemic gene therapy with p53 inhibits growth of a malignant human breast cancer in nude mice. Hum Gen Ther 6: 395-405, 1995
33. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM, Johnson DE, Anderson SC, Wen SF: Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gen Ther 5: 1079-88, 1994
34. Cook DR, Maxwell IH, Glode LM, Maxwell F, Stevens JO, Purner MB, Wagner E, Curiel DT, Curiel TJ: Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphteria toxin gene delivered by a novel adenovirus-polylysine conjugate. Cancer Biother 9: 131-41, 1994
35. Drazan KE, Shen XD, Csete ME, Zhang WW, Roth JA, Busuttil RW, Shaked A: In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116: 197-203, 1994
36. Clayman Gl, El-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6 1995
37. Yamada M, Shimizu K, Miyao Y, Hayakawa T, Ikenaka K, Nakahira K, Nakajima K, Kagawa T, Mikoshiba K: Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain. Jpn J Cancer Res 83: 1244-7, 1992
38. Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowal NW, Hochberg FH, Waxman DJ, Breakefield XO, Chiocca EA: Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene. Hum Gen Ther 5: 969-78, 1994
39. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-7, 1994
40. Badie B, Hunt K, Economou JS, Black KL: Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery 35: 910-5, 1994
41. Rousculp MD, Goldsmith KT, Garver RI Jr: Quantitative evaluation of retroviral gene transduction efficiency in human lung cancer cells. Hum Gen Ther 3: 471-7, 1992
42. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck Sj, Wilson JM, Albelda SM: Succesful Adenovirusmediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thor Surg 57: 1395-401, 1994
43. Hofland H, Huang L: Inhibition of human ovarian cacinoma cell proliferation by liposome-plasmid DNA complex. Bioch Bioph Res Commun 207: 492-6, 1995
44. Kuriyama S, Yoshikawa M, Ishizaka S, Tsujii T, Ikenaka K, Kagawa T, Morita N, Mikoshiba K: A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on retroviral vector. Cell Struct Funct 16: 503-10, 1991
45. Allen TM: Long-circulating (sterically-stabilised) liposomes for targeted drug delivery. TIPS 15: 215-220, 1994
46. Walther FJ, David-Cu R, Supnet MC, Longo ML, Fan BR, Bruni R: Uptake of antioxidants in surfactant liposomes is enhanced by SP-A. Am J Physiol 265: L330-L339, 1993
47. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ: Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension 21: 894-899, 1993
48. Schreier H, Gonzalez-Rothi RJ, Stecenko AA: Pulmonary delivery of liposomes. J Contr Release 24: 209-223, 1993
49. Mizuno M, Yoshida J, Sugita K, Hayashi Y, Yagi K: Basic research for interferon gene therapy against malignant glioma. No Shinkei Geka - Neurol Sur 20: 547-51, 1992
50. Yoshida J, Mizuno M: Simple method to prepare cationic multilamellar liposomes for efficient transfection of human interferon-beta gene to human glioma cells. J Neuro-Oncol 19: 269-74, 1994
51. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193, 1994
52. Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturn S, Selegue J, London W, Blaese RM, Anderson WF: Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum Gen Ther 1: 15-30, 1990
53. Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA: A retroviral Wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res 53: 4129-4133, 1993
54. Ram Z, Culver KW, Walbridge R, Blaese RM, Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rat. Cancer Res 53: 83-88, 1993
55. Shimizu K: Selective gene therapy of malignant gliomas using brain-specific promoters: its efficacy and basic investigations. Jpn J Clin Med 52: 3053-8, 1994
56. Green M, Wold WSM, Mackey JK, Rigden P: Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, 6) human adenoviruses. Proc Natl Acad Sci USA 76: 6606-6610, 1979
57. Wold WSM, Mackey JK, Rigden P, Green M: Analysis of human cancer DNAs for DNA sequences of human adenovirus serotypes 3, 7, 11, 14, 16, and 21 in group B. Cancer Res 39: 3479-3484, 1979
58. Zhang W-W, Alemany R, Wang J, Koch PE, Ordonez NG, Roth JA: Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum Gen Ther 6: 155-164, 1995
59. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR: Spatial and temporal control of gene therapy using ionizing radiation. Nature Med 1: 786-791, 1995
60. Liu TJ;, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL: Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54: 3662-3667, 1994
61. Liu T-J, El-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL: Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 55: 3117-3122, 1995
62. Yang C, Cirielli C, Capogrossi MC, Passaniti A: Adenovirus-mediated wild type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 55: 4210-4213, 1995
63. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, Capogrossi MC: Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 63: 673-79, 1995
64. Yang Z-Y, Perkins ND, Ohno T, Nabel EG, Nabel GJ: The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med 1: 1052-1056, 1995
65. Jin X, Nguyen D, Zhang W-W, Kyritsis AP, Roth JA: Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res 55: 3250-3253, 1995
66. Greenbaum M, Letourneau S, Assar H, Schecter RL, Batist G, Cournoyer D: Retrovirus-mediated gene transfer of rat glutathione-S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res 54: 4442-4447, 1994
67. Huang XM, Wei SG, Wang LF: Reversal of malignant phenotype of human hepatoma cells by antisense c-ets-2, c-myc, and N-ras. Chin J Oncol 16: 243-246, 1994